Pharmacies as Innovative Settings for Promoting HIV PrEP Adherence

Pharmacies as Innovative Settings for Promoting HIV PrEP Adherence. Lorraine Dean, ScD, Social Epidemiologist and Associate Professor in Epidemiology, Johns Hopkins Bloomberg School of Public Health.
About INSIGHTS (Innovative Non-traditional Healthcare Settings in HIV Research Lecture Series): The purpose of this lecture series is to provide the community of HIV researchers with space and time to hear about innovative research conducted outside of traditional healthcare settings. This research includes any HIV-related interventions that can be applied to HIV research, including those that are conducted outside of the clinic (e.g., pharmacy, patients’ homes, CBO, mobile vans unrelated to the clinic, outdoors), can increase access to medications without involving clinics, or can enhance PrEP or ART adherence and persistence without clinic input. This lecture series is funded by the UCSF CFAR Boost Award.
Learning Objectives:
• Understand the potential role of pharmacies and pharmacists on the PrEP care continuum
• Introduce “PrEP pharmacy reversals” as a novel pharmacy-based metric for PrEP adherence
• Review opportunities for pharmacies to be engaged in PrEP care
Sign up for our quarterly CAPS/PRC e-newsletter - lp.constantcontactpages.com/s...
UCSF Prevention Science Linkedin / ucsf-dps
Dr. Lorraine Dean is an Associate Professor in Epidemiology at Johns Hopkins Bloomberg School of Public Health. As a social epidemiologist, her work focuses on privilege and health, including social (racism, discrimination, social capital) and economic (consumer credit, socioeconomic position, guaranteed income) determinants of disparities in chronic disease.
This presentation is hosted by CAPS/DPS/PRC Town Hall and the CAPS Developmental Core as part of a Special Lecture Series: INSIGHTS Lecture Series: Innovative Non-traditional Healthcare Settings in HIV Research. Town Hall Chair: Parya Saberi, PharmD.
0:00 Introductions
2:54 Pharmacies as Innovative Settings
5:06 What is HIV PrEP?
6:15 Challenges with Oral PrEP Retention
7:23 Conceptual Model for PrEP Prescription
8:46 Study: Assessing Gaps in PrEP Initiation using Pharmacy Claims Data
12:54 Methods: Claim Data
14:27 Demographics: Newly Prescribed PrEP
18:21 Predicted PrEP Abandonment Rate
21:36 Study: Patient and Pharmacist Perspectives on Mised HIV PrEP Pickups
26:33 Topics for Qualitative Interviews
27:52 Individual-Level Barriers to Increasing PrEP Access at Pharmacies
29:34 Structural-Level Barriers
32:14 Application to PrEP Pharmacy Interventions
33:57 Pharmacy-Based Intervention Strategies
40:46 Results in California so far
43:28 Next Steps
44:35 Q & A and Discussion
Recorded Tuesday, April 2nd, 2024